Overall rank by patents
#2,527
Across all tracked assignees
USPTO PatentsView assignee record - 154 granted patents across 77 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C01B (NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; ; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C).
The verdict
Lyten holds 154 US patents across 77 technology areas, rank #2,527 of 50,000 tracked assignees.
Lyten, Inc. has been granted 154 US utility patents between 2017 and 2025, placing Lyten, Inc. at rank #2,527 across all assignees tracked by PlainPatent. This portfolio spans 77 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.5 claims per patent with primary concentration in C01B (NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; ; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C). As a US Corporation, Lyten, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Lyten sits between Cancer Research Technology Limited (154 patents, rank #2,523) and Polestar Performance AB (154 patents, rank #2,531) - the closest US assignees by grant volume. The composite Innovation Score of 70.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 137 grants, compared with 17 in the 2015–2019 window, a +706% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Lyten, Inc.'s 20.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 77 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Lyten, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Cancer Research Technology Limited
154 patents
Citizen Holdings Co., Ltd.
154 patents
HannStar Display Corporation
154 patents
LUMENS CO., LTD.
154 patents
Life Spine, Inc.
154 patents
MELEXIS TECHNOLOGIES SA
154 patents
Oregon State University
154 patents
Polestar Performance AB
154 patents
LYTEN, INC.
154 patents
What this shows Lyten holds 154 patents at rank #2,527, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,527 in granted patent volume.
Other assignees with the most granted patents in Lyten's primary technology class.
Lyten's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
71 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 1.3% |
| 2018 | 4 | 2.6% |
| 2019 | 11 | 7.1% |
| 2020 | 9 | 5.8% |
| 2021 | 15 | 9.7% |
| 2022 | 21 | 13.6% |
| 2023 | 31 | 20.1% |
| 2024 | 32 | 20.8% |
| 2025 | 29 | 18.8% |
Top 15 of 77 technology areas
Overall rank by patents
#2,527
Across all tracked assignees
70.7 out of 100
How to use this portfolio
Lyten's 154 grants land it in the top 0.1% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.